Inhaled nitric oxide improves post-cardiac arrest outcomes via guanylate cyclase-1 in bone marrow-derived cellsNITRIC OXIDE-BIOLOGY AND CHEMISTRYIF3.22022-08-011OAAI
Dissociation between urate and blood pressure in mice and in people with early Parkinson's diseaseEBIOMEDICINEIF10.82018-11-0110OAAI
The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl CyclaseINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72017-09-2629OAAI
Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in MiceANTIOXIDANTS & REDOX SIGNALINGIF6.12017-02-0120OAAI
Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in miceNATURE COMMUNICATIONSIF15.72015-10-0765OAAI
Pulmonary Hypertension after Prolonged Hypoxic Exposure in Mice with a Congenital Deficiency of Cyp2jAMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGYIF5.32015-05-0114OAAI
A role for 20-HETE in the development of gender- and strain-specific hypertension in soluble guanylate cyclase alpha1-deficient miceNITRIC OXIDE-BIOLOGY AND CHEMISTRYIF3.22014-11-010PREAI
Heme-deficient NO-unresponsive sGC knock-in mice: Novel aspects of NO sGC signaling in cardiovascular (patho)physiologyNITRIC OXIDE-BIOLOGY AND CHEMISTRYIF3.22014-11-010PREAI
Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice (vol 122, pg 2316, 2012)JOURNAL OF CLINICAL INVESTIGATIONIF13.62012-08-010OA
Identification of renin signaling as a blood pressure modifying mechanism in soluble guanylate cyclase α1-deficient miceNITRIC OXIDE-BIOLOGY AND CHEMISTRYIF3.22012-07-010PREAI
Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient miceJOURNAL OF CLINICAL INVESTIGATIONIF13.62012-06-0130OA